|
1
|
Kivelä T: The epidemiological challenge of
the most frequent eye cancer: retinoblastoma, an issue of birth and
death. Br J Ophthalmol. 93:1129–1131. 2009.PubMed/NCBI
|
|
2
|
Rodriguez-Galindo C, Wilson MW, Chantada
G, et al: Retinoblastoma: one world, one vision. Pediatrics.
122:e763–e770. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Friend SH, Bernards R, Rogelj S, et al: A
human DNA segment with properties of the gene that predisposes to
retinoblastoma and osteosarcoma. Nature. 323:643–646. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Corson TW and Gallie BL: One hit, two
hits, three hits, more? Genomic changes in the development of
retinoblastoma. Genes Chromosomes Cancer. 46:617–634. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dimaras H, Khetan V, Halliday W, et al:
Loss of RB1 induces non-proliferative retinoma: increasing genomic
instability correlates with progression to retinoblastoma. Hum Mol
Genet. 17:1363–1372. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dyer MA and Bremner R: The search for the
retinoblastoma cell of origin. Nat Rev Cancer. 5:91–101. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kidd S, Lockett TJ and Young MW: The Notch
locus of Drosophila melanogaster. Cell. 34:421–433. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mullendore ME, Koorstra JB, Li YM, et al:
Ligand-dependent Notch signaling is involved in tumor initiation
and tumor maintenance in pancreatic cancer. Clin Cancer Res.
15:2291–2301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nam DH, Jeon HM, Kim S, et al: Activation
of notch signaling in a xenograft model of brain metastasis. Clin
Cancer Res. 14:4059–4066. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
South AP, Cho RJ and Aster JC: The
double-edged sword of Notch signaling in cancer. Semin Cell Dev
Biol. 23:458–464. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aguirre A, Rubio ME and Gallo V: Notch and
EGFR pathway interaction regulates neural stem cell number and
self-renewal. Nature. 467:323–327. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zayzafoon M, Abdulkadir SA and McDonald
JM: Notch signaling and ERK activation are important for the
osteomimetic properties of prostate cancer bone metastatic cell
lines. J Biol Chem. 279:3662–3670. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ye YZ, Zhang ZH, Fan XY, et al: Notch3
overexpression associates with poor prognosis in human
non-small-cell lung cancer. Med Oncol. 30:5952013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reichrath J and Reichrath S:
Notch-signaling and nonmelanoma skin cancer: an ancient friend,
revisited. Adv Exp Med Biol. 727:265–271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Purow B: Notch inhibition as a promising
new approach to cancer therapy. Adv Exp Med Biol. 727:305–319.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Miele L, Miao H and Nickoloff BJ: NOTCH
signaling as a novel cancer therapeutic target. Curr Cancer Drug
Targets. 6:313–323. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bin Hafeez B, Adhami VM, Asim M, et al:
Targeted knockdown of Notch1 inhibits invasion of human prostate
cancer cells concomitant with inhibition of matrix
metalloproteinase-9 and urokinase plasminogen activator. Clin
Cancer Res. 15:452–459. 2009.
|
|
18
|
Chiron D, Maïga S, Descamps G, et al:
Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma
cells. Blood Cells Mol Dis. 48:247–253. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang TH, Liu HC, Zhu LJ, et al:
Activation of Notch signaling in human tongue carcinoma. J Oral
Pathol Med. 40:37–45. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang Y, Ahn YH, Gibbons DL, et al: The
Notch ligand Jagged2 promotes lung adenocarcinoma metastasis
through a miR-200-dependent pathway in mice. J Clin Invest.
121:1373–1385. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodilla V, Villanueva A, Obrador-Hevia A,
et al: Jagged1 is the pathological link between Wnt and Notch
pathways in colorectal cancer. Proc Natl Acad Sci USA.
106:6315–6320. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen SM, Liu JP, Zhou JX, et al:
Suppression of the notch signaling pathway by gamma-secretase
inhibitor GSI inhibits human nasopharyngeal carcinoma cell
proliferation. Cancer Lett. 306:76–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shao H, Huang Q and Liu ZJ: Targeting
Notch signaling for cancer therapeutic intervention. Adv Pharmacol.
65:191–234. 2012. View Article : Google Scholar
|
|
24
|
Guo D, Ye J, Dai J, et al: Notch-1
regulates Akt signaling pathway and the expression of cell cycle
regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines.
Leuk Res. 33:678–685. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu ZJ, Xiao M, Balint K, et al: Notch1
signaling promotes primary melanoma progression by activating
mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt
pathways and up-regulating N-cadherin expression. Cancer Res.
66:4182–4190. 2006. View Article : Google Scholar
|
|
26
|
Mungamuri SK, Yang X, Thor AD and
Somasundaram K: Survival signaling by Notch1: mammalian target of
rapamycin (mTOR)-dependent inhibition of p53. Cancer Res.
66:4715–4724. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo D, Teng Q and Ji C: NOTCH and
phosphatidylinositide 3-kinase/phosphatase and tensin homolog
deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR)
signaling in T-cell development and T-cell acute lymphoblastic
leukemia. Leuk Lymphoma. 52:1200–1210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mohan A, Mallikarjuna K, Venkatesan N,
Abhyankar D, Parikh PM and Krishnakumar S: The study of c-Src
kinase and pStat3 protein expression in retinoblastoma. Exp Eye
Res. 83:736–740. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ishizawar R and Parsons SJ: c-Src and
cooperating partners in human cancer. Cancer Cell. 6:209–214. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma YC, Shi C, Zhang YN, et al: The
tyrosine kinase c-Src directly mediates growth factor-induced
Notch-1 and Furin interaction and Notch-1 activation in pancreatic
cancer cells. PLoS One. 7:e334142012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen YS, Wu MJ, Huang CY, Lin SC, Chuang
TH, Yu CC and Lo JF: CD133/Src axis mediates tumor initiating
property and epithelial-mesenchymal transition of head and neck
cancer. PLoS One. 6:e280532011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reya T and Clevers H: Wnt signalling in
stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tell S, Yi H, Jockovich ME, Murray TG and
Hackam AS: The Wnt signaling pathway has tumor suppressor
properties in retinoblastoma. Biochem Biophys Res Commun.
349:261–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hahne G and Grossmann TN: Direct targeting
of beta-catenin: Inhibition of protein-protein interactions for the
inactivation of Wnt signaling. Bioorg Med Chem. 21:4020–4026. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kondoh K, Sunadome K and Nishida E: Notch
signaling suppresses p38 MAPK activity via induction of MKP-1 in
myogenesis. J Biol Chem. 282:3058–3065. 2007. View Article : Google Scholar : PubMed/NCBI
|
